{"id":"fluticasone-propionate-montelukast","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Cough"},{"rate":"5-10%","effect":"Throat irritation"},{"rate":"5-10%","effect":"Nausea"},{"rate":"1-5%","effect":"Vomiting"},{"rate":"1-5%","effect":"Dysphonia"},{"rate":"1-5%","effect":"Oral candidiasis"},{"rate":"1-5%","effect":"Hypersensitivity reactions"},{"rate":"1-5%","effect":"Increased risk of pneumonia"},{"rate":"1-5%","effect":"Osteoporosis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Fluticasone propionate works by inhibiting the release of pro-inflammatory mediators, thereby reducing inflammation in the airways. Montelukast, on the other hand, blocks the action of leukotrienes, which are substances that cause bronchospasm and increase mucus production.","oneSentence":"Fluticasone propionate is a corticosteroid that reduces inflammation, while montelukast is a leukotriene receptor antagonist that prevents bronchospasm.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:13:05.104Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic asthma"},{"name":"Allergic rhinitis"}]},"trialDetails":[{"nctId":"NCT05922761","phase":"PHASE2","title":"BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-05-31","conditions":"Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases","enrollment":45},{"nctId":"NCT04885530","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-06-08","conditions":"Covid19","enrollment":10956},{"nctId":"NCT05457855","phase":"","title":"Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2022-02-01","conditions":"Asthma","enrollment":51533},{"nctId":"NCT04480242","phase":"","title":"Asthma Research in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Parc de Salut Mar","startDate":"2017-07-26","conditions":"Persistent Asthma, Asthma in Children, Asthma Exacerbation","enrollment":525},{"nctId":"NCT06806826","phase":"PHASE4","title":"The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2019-01-01","conditions":"Allergic Rhinitis","enrollment":50},{"nctId":"NCT03072849","phase":"","title":"Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation","status":"COMPLETED","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2015-04","conditions":"Bronchiolitis Obliterans Syndrome","enrollment":23},{"nctId":"NCT00545324","phase":"PHASE4","title":"First Step With Singulair® Therapy (0476-323)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-09","conditions":"Asthma","enrollment":399},{"nctId":"NCT00489346","phase":"PHASE3","title":"A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-10","conditions":"Asthma, Bronchial","enrollment":994},{"nctId":"NCT04527016","phase":"PHASE4","title":"Airway Microbiota Based Treatment of Asthma in Preschool Children","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2021-10-18","conditions":"Asthma in Children","enrollment":120},{"nctId":"NCT00394355","phase":"PHASE4","title":"Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Asthma","enrollment":566},{"nctId":"NCT00127166","phase":"PHASE3","title":"Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-12","conditions":"Exercise Induced Asthma","enrollment":154},{"nctId":"NCT00284856","phase":"PHASE3","title":"Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-05","conditions":"Asthma","enrollment":1640},{"nctId":"NCT02889809","phase":"PHASE4","title":"Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-07-10","conditions":"Asthma","enrollment":477},{"nctId":"NCT05651750","phase":"PHASE4","title":"Medical vs Surgical Treatment in OSA Among Children","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2022-11-15","conditions":"To Evaluate PSQ as Clinical Tool in the Decision Between Medical and Surgical Treatment for Adenotonsillar Hypertrophy, To Determine Clinical Response to Montelukast or Nasal Steroids Based on PSQ Results","enrollment":90},{"nctId":"NCT01103349","phase":"PHASE2","title":"BI 671800 in Asthmatic Patients on Inhaled Corticosteroids","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2010-04-20","conditions":"Asthma","enrollment":243},{"nctId":"NCT05381207","phase":"EARLY_PHASE1","title":"Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory Makers","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-10","conditions":"Allergic Rhinitis","enrollment":60},{"nctId":"NCT05143502","phase":"PHASE1, PHASE2","title":"Role of Montelukast in the Management of Chronic Rhinosinusitis With Nasal Polyps.","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-01-01","conditions":"Montelukast, Chronic Rhinosinusitis With Nasal Polyps","enrollment":60},{"nctId":"NCT00540839","phase":"PHASE3","title":"A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2007-11","conditions":"Asthma, Bronchial","enrollment":""},{"nctId":"NCT04957927","phase":"PHASE4","title":"Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age","status":"UNKNOWN","sponsor":"Usama Azhar","startDate":"2020-12-12","conditions":"Allergic Rhinitis","enrollment":60},{"nctId":"NCT04953741","phase":"PHASE4","title":"A Comparative Study on the Efficacy of Different Stepping-down Therapy for Childhood Asthma","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2021-08-01","conditions":"Asthma in Children","enrollment":90},{"nctId":"NCT02483975","phase":"PHASE3","title":"Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-10-09","conditions":"Asthma","enrollment":111},{"nctId":"NCT01702701","phase":"PHASE3","title":"Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone","status":"WITHDRAWN","sponsor":"Medical College of Wisconsin","startDate":"2012-01","conditions":"Eosinophilic Esophagitis, Dysphagia","enrollment":""},{"nctId":"NCT01696214","phase":"PHASE4","title":"A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2012-10","conditions":"Asthma","enrollment":20},{"nctId":"NCT00395304","phase":"PHASE3","title":"Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2007-03","conditions":"Asthma","enrollment":182},{"nctId":"NCT01307462","phase":"PHASE2","title":"Targeted Therapy of Bronchiolitis Obliterans Syndrome","status":"COMPLETED","sponsor":"Stephanie Lee","startDate":"2011-06","conditions":"Bronchiolitis Obliterans","enrollment":36},{"nctId":"NCT01147744","phase":"PHASE2","title":"Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-06-28","conditions":"Asthma","enrollment":700},{"nctId":"NCT01328964","phase":"","title":"Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-06","conditions":"Asthma","enrollment":9906},{"nctId":"NCT01156792","phase":"PHASE2","title":"Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-09","conditions":"Asthma","enrollment":162},{"nctId":"NCT01606306","phase":"PHASE3","title":"Individualized Therapy For Asthma in Toddlers","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2013-02","conditions":"Asthma, Wheezing","enrollment":300},{"nctId":"NCT00328718","phase":"PHASE3","title":"Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-10","conditions":"Asthma","enrollment":526},{"nctId":"NCT00296491","phase":"PHASE4","title":"Study Of Allergic Rhinitis In Patients Who Also Have Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-09","conditions":"Asthma","enrollment":725},{"nctId":"NCT01248975","phase":"PHASE2","title":"Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-12","conditions":"Asthma","enrollment":145},{"nctId":"NCT00296530","phase":"PHASE4","title":"Study Of Patients With Allergic Rhinitis And Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-09","conditions":"Asthma","enrollment":600},{"nctId":"NCT00385463","phase":"NA","title":"Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo","status":"WITHDRAWN","sponsor":"Creighton University","startDate":"2006-04","conditions":"Asthma, Seasonal Allergic Rhinitis","enrollment":""},{"nctId":"NCT00156819","phase":"PHASE4","title":"The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial","status":"COMPLETED","sponsor":"JHSPH Center for Clinical Trials","startDate":"2003-06","conditions":"Asthma","enrollment":500},{"nctId":"NCT01007721","phase":"PHASE2","title":"Randomized, Placebo Controlled, Crossover Study in an Environmental Challenge Chamber to Assess Safety & Efficacy of Three Oral Doses of BI 671800 Versus Fluticasone Propionate and Montelukast in Sensitive Seasonal Allergic Rhinitis Patients Out of Season","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2009-10","conditions":"Rhinitis, Allergic, Seasonal, Asthma","enrollment":146},{"nctId":"NCT00119015","phase":"PHASE4","title":"The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2005-07","conditions":"Rhinitis, Allergic, Perennial","enrollment":102},{"nctId":"NCT00961155","phase":"PHASE2","title":"Usefulness of Exhaled Breath Condensate for Evaluation of Markers of Airway Inflammation in Children With Asthma","status":"UNKNOWN","sponsor":"Medical University of Lodz","startDate":"2009-08","conditions":"Asthma","enrollment":200},{"nctId":"NCT01240889","phase":"NA","title":"Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*","status":"COMPLETED","sponsor":"Creighton University","startDate":"2010-11","conditions":"Allergy","enrollment":60},{"nctId":"NCT00712335","phase":"PHASE4","title":"The Effects of Montelukast on Smokers With Asthma","status":"COMPLETED","sponsor":"Inje University","startDate":"2007-02","conditions":"Asthmatic Smokers, Non-asthmatic Smokers","enrollment":105},{"nctId":"NCT01526161","phase":"PHASE4","title":"Management of Asthma in School-age Children on Therapy","status":"COMPLETED","sponsor":"Professor Warren Lenney","startDate":"2009-04","conditions":"Asthma","enrollment":229},{"nctId":"NCT01488773","phase":"","title":"Comparison of Two Treatment Regimens in Asthmatic Patients","status":"COMPLETED","sponsor":"Medical University of Lodz","startDate":"1995-04","conditions":"Asthma","enrollment":132},{"nctId":"NCT00655616","phase":"NA","title":"Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2007-08","conditions":"Asthma","enrollment":64},{"nctId":"NCT00252863","phase":"PHASE3","title":"DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2004-12","conditions":"Asthma","enrollment":1600},{"nctId":"NCT00543686","phase":"PHASE2","title":"Leukotriene Receptor Antagonists or Steroids in Pre-School Asthma","status":"COMPLETED","sponsor":"Johann Wolfgang Goethe University Hospital","startDate":"2007-08","conditions":"Asthma","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":242,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Flovent Diskus® + Singulair®"],"phase":"phase_3","status":"active","brandName":"fluticasone propionate + montelukast","genericName":"fluticasone propionate + montelukast","companyName":"Milton S. Hershey Medical Center","companyId":"milton-s-hershey-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fluticasone propionate is a corticosteroid that reduces inflammation, while montelukast is a leukotriene receptor antagonist that prevents bronchospasm. Used for Chronic asthma, Allergic rhinitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}